rss
J Neurol Neurosurg Psychiatry 2008;79:387-391 doi:10.1136/jnnp.2007.116830
  • Research paper

Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson’s disease over time

  1. M D Gjerstad1,2,
  2. B Boeve3,
  3. T Wentzel-Larsen4,
  4. D Aarsland1,5,6,
  5. J P Larsen1,2,6
  1. 1
    The Norwegian Centre for Movement Disorders, Stavanger, Norway
  2. 2
    Department of Neurology, Stavanger University Hospital, Stavanger, Norway
  3. 3
    Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA
  4. 4
    Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway
  5. 5
    Department of Psychiatry, Stavanger University Hospital, Stavanger, Norway
  6. 6
    Institute of Clinical Medicine, University of Bergen, Bergen, Norway
  1. Michaela D Gjerstad, The Norwegian Centre for Movement Disorders, Stavanger, Norway, PB 8100, N-4068 Stavanger, Norway; gjmi{at}sus.no
  • Received 29 January 2007
  • Revised 8 May 2007
  • Accepted 15 May 2007
  • Published Online First 8 June 2007

Abstract

Objective: To examine the occurrence and clinical and demographic correlates of REM sleep behaviour disorder (RBD) in patients with Parkinson’s disease (PD) in a community-based cohort over 8 years.

Methods: 231 patients with PD were included in a population-based prevalence study in 1993. Patients were then followed prospectively and reexamined after 4 and 8 years. Semi-structured interviews for information on clinical and demographic data were applied at all study visits. Standardised rating scales of parkinsonism, depression and cognitive impairment were used. The diagnosis of probable RBD (pRBD) was based on a sleep questionnaire. Proportional-odds ordinal logistic regression models for clustered data were used to study the relationship between pRBD and various demographic and clinical variables.

Results: 231 patients were evaluated for RBD in 1993 and, after 4 and 8 years, 142 and 89 patients, respectively, were available for re-evaluation. The frequency of pRBD varied from 14.6% to 27% during the study period. Probable RBD was related to male gender, higher dopaminergic treatment and less severe parkinsonism.

Conclusion: We found that the frequency of pRBD varied over time and that it is associated with male gender, less parkinsonism and higher levodopa equivalent dose. Our findings indicate that dopaminergic therapy may contribute to the expression of RBD and that RBD is symptomatic in earlier stages of PD.

Footnotes

  • Competing interests: None.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. jnnp.2007.116830v1
    2. 79/4/387 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest neurology and neurosurgery jobs